RxDoctor Payments DataLook up a doctor →

Teresa Sligh

Internal Medicine · Burbank, CANPI 1720350929

Payments from drug & device makers

$4,719,719in general payments, 2019–2025

Across 459 payments — averaging $10,283 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$1.3M
  • Hikma Pharmaceuticals USA$962K
  • AbbVie$744K
  • AstraZeneca$443K
  • Teva Pharmaceuticals USA, Inc.$334K
  • Ironwood Pharmaceuticals, Inc$206K
  • plus $744K from 18 others
$113,025in research payments, 2019–2025

Across 17 payments — averaging $6648.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$67K
  • Pfizer$45K
  • Gilead$2K

What the payments were for

  • Consulting fees$1,68094%
  • Food & beverage$201%
  • Education$654%
  • Gifts$201%

General payments by program year

19
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,719,719 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Other internal medicine in Burbank

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →